Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
129.2 USD | -0.11% | -0.58% | +13.01% |
Mar. 12 | BNP Paribas Exane Starts Xylem With Outperform Rating, $150 Price Target | MT |
Mar. 05 | Xylem Insider Sold Shares Worth $3,692,158, According to a Recent SEC Filing | MT |
Evolution of the average Target Price on Xylem Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Xylem Inc.
BNP Paribas Exane | |
Oppenheimer | |
Citigroup | |
Baird | |
Stifel Nicolaus | |
RBC Capital Markets | |
Deutsche Bank Securities | |
Melius Research | |
Seaport Global Securities | |
Goldman Sachs | |
Cowen | |
Morgan Stanley | |
Mizuho Securities | |
Raymond James | |
Atlantic Equities | |
Credit Suisse | |
Argus | |
Berenberg Bank | |
Loop Capital | |
Rosenblatt Securities |
EPS Revisions
- Stock
- Equities
- Stock Xylem Inc. - Nyse
- Consensus Xylem Inc.